The enhanced diagnostic accuracy of these modified indices likely stems from their ability to simultaneously evaluate two fundamental NAFLD pathways: 1) insulin resistance (represented by the TyG index) and 2) dysfunctional adipose tissue distribution and physiology (represented by the anthropometric measures). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.